Replies to post #117930 on Cytodyn Inc (CYDY)

[justdafactss]

Leronlimab is worthless. No CEO, clinical trial patient enrollment, DSMB, or anything else will change that fact.

CYDY had a fair shot at proving/meeting its primary endpoint and it failed.

Its over.